Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yudai Hayashi
Observed name:
Hayashi, Yudai
Institutions:
Tokyo Metropolitan Komagome Hospital,
Tokyo Metropolitan Tama Medical Center
Observed institutions:
Tokyo Metropolitan Komagome Hospital,
Tokyo Metropolitan Tama Medical Center
ORCID:
0009-0009-2539-6316
Observed ORCID:
0009-0009-2539-6316
OpenAlex ID:
A5025646431
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma
2023
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
Annals of Hematology
·
11
Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study
2023
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
Cancer Medicine
·
9
PDF
Successful Treatment of Steroid-Refractory Immune Thrombocytopenia in a Patient Developing Multiple Myeloma While on Immune Checkpoint Inhibitor Therapy for Lung Cancer: A Case Report
2024
·
Yudai Hayashi
, Masao Tsukada
, et al.
·
Journal of Blood Medicine
·
5
PDF
[Tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma: real-world data from single institute experience].
2022
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
PubMed
·
4
Hemoglobin‐platelet index as a prognostic factor in patients with peripheral T‐cell lymphoma
2023
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
eJHaem
·
3
PDF
Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy
2024
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
Journal of the Japan Society of the Reticuloendothelial System
·
2
Site‐ and Stage‐Adapted Treatment Strategies for Gastrointestinal Diffuse Large B‐Cell Lymphoma
2025
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
European Journal Of Haematology
·
1
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant].
2023
·
Yuka Morita
, Yu Yagi
, et al.
·
PubMed
·
1
Giant topological magneto-optical effect in noncoplanar antiferromagnet
2026
·
Okamura, Yoshihiro
, Hayashi, Yudai
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Flow Cytometry-Aided Early Diagnosis and Alectinib Response in Advanced ALK-Positive Large B-Cell Lymphoma: A Case Report
2025
·
Yudai Hayashi
, Masao Tsukada
, et al.
·
Research Square
PDF
Combined Impact of Prior Polatuzumab Vedotin Plus Bendamustine and Rituximab Therapy and Myeloablative Conditioning on Early Post-Transplant BK Virus-Associated Hemorrhagic Cystitis
2025
·
Yudai Hayashi
, Masao Tsukada
, et al.
·
Journal of Hematology
PDF
P1153: Utility of the Frailty Score for Predicting Prognosis and Individualizing Treatment Intensity in Elderly Patients With Diffuse Large B-cell Lymphoma
2023
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
HemaSphere
Show more works
View as search
Works count:
12
Citation count:
36
H-index:
4
I10-index:
1
Year
Topic
Type